Concepts (174)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tumor Suppressor Protein p53 | 12 | 2011 | 318 | 1.900 |
Why?
|
| Cell Cycle Proteins | 5 | 2011 | 402 | 0.690 |
Why?
|
| Glucose | 2 | 2015 | 476 | 0.620 |
Why?
|
| Serine | 3 | 2010 | 90 | 0.540 |
Why?
|
| Apoptosis | 5 | 2010 | 1098 | 0.520 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2015 | 42 | 0.430 |
Why?
|
| Signal Transduction | 10 | 2015 | 3153 | 0.420 |
Why?
|
| Prediabetic State | 1 | 2015 | 54 | 0.420 |
Why?
|
| Insulin Resistance | 2 | 2015 | 414 | 0.410 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2011 | 210 | 0.390 |
Why?
|
| Fibroblasts | 8 | 2015 | 422 | 0.370 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2010 | 205 | 0.370 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2011 | 583 | 0.340 |
Why?
|
| Nuclear Localization Signals | 1 | 2010 | 20 | 0.330 |
Why?
|
| Neural Tube Defects | 1 | 2010 | 28 | 0.330 |
Why?
|
| DNA-Binding Proteins | 4 | 2011 | 1225 | 0.320 |
Why?
|
| Mitogen-Activated Protein Kinases | 5 | 2003 | 213 | 0.320 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 6 | 2006 | 141 | 0.320 |
Why?
|
| Lymphoma, B-Cell | 1 | 2010 | 63 | 0.300 |
Why?
|
| Phosphorylation | 7 | 2011 | 962 | 0.300 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 4 | 1997 | 35 | 0.300 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2010 | 113 | 0.290 |
Why?
|
| Protein Kinases | 5 | 2007 | 153 | 0.290 |
Why?
|
| Homeostasis | 1 | 2010 | 379 | 0.270 |
Why?
|
| Mice, Inbred C57BL | 7 | 2015 | 3485 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 731 | 0.260 |
Why?
|
| Mice | 13 | 2015 | 11119 | 0.260 |
Why?
|
| DNA Fragmentation | 1 | 2006 | 34 | 0.250 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 3 | 2011 | 43 | 0.230 |
Why?
|
| Animals | 16 | 2015 | 21345 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-jun | 5 | 2007 | 34 | 0.210 |
Why?
|
| Nuclear Proteins | 2 | 2010 | 790 | 0.210 |
Why?
|
| Drosophila | 2 | 1997 | 480 | 0.200 |
Why?
|
| Histones | 1 | 2006 | 494 | 0.190 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2015 | 604 | 0.180 |
Why?
|
| Drosophila Proteins | 2 | 1997 | 758 | 0.170 |
Why?
|
| Germ-Line Mutation | 2 | 2011 | 47 | 0.150 |
Why?
|
| Animals, Genetically Modified | 2 | 2010 | 312 | 0.150 |
Why?
|
| Insulin | 2 | 2015 | 695 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2015 | 2188 | 0.140 |
Why?
|
| Antioxidants | 2 | 2010 | 249 | 0.140 |
Why?
|
| Mice, Knockout | 4 | 2015 | 2157 | 0.130 |
Why?
|
| Insect Proteins | 1 | 1997 | 83 | 0.130 |
Why?
|
| Cell Proliferation | 2 | 2011 | 1037 | 0.120 |
Why?
|
| Cellular Senescence | 2 | 2007 | 120 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1996 | 58 | 0.120 |
Why?
|
| Mutation | 4 | 2011 | 2661 | 0.120 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 4 | 2010 | 46 | 0.120 |
Why?
|
| Proto-Oncogene Proteins | 4 | 2004 | 341 | 0.120 |
Why?
|
| Amino Acid Sequence | 4 | 2010 | 1589 | 0.110 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 1 | 2015 | 4 | 0.110 |
Why?
|
| Protein Phosphatase 2C | 1 | 2015 | 3 | 0.110 |
Why?
|
| Diet, Fat-Restricted | 1 | 2015 | 34 | 0.110 |
Why?
|
| Primary Cell Culture | 1 | 2015 | 80 | 0.110 |
Why?
|
| Leptin | 1 | 2015 | 88 | 0.110 |
Why?
|
| Glucose Intolerance | 1 | 2015 | 90 | 0.100 |
Why?
|
| Ultraviolet Rays | 2 | 2010 | 147 | 0.100 |
Why?
|
| Dietary Fats | 1 | 2015 | 180 | 0.100 |
Why?
|
| Diet, High-Fat | 1 | 2015 | 180 | 0.100 |
Why?
|
| Interleukin-6 | 1 | 2015 | 323 | 0.100 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 2 | 2010 | 86 | 0.090 |
Why?
|
| Reactive Oxygen Species | 2 | 2010 | 237 | 0.090 |
Why?
|
| Cell Division | 3 | 2007 | 449 | 0.090 |
Why?
|
| Peroxidases | 1 | 2010 | 6 | 0.080 |
Why?
|
| Genes, ras | 1 | 2010 | 28 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 730 | 0.080 |
Why?
|
| Ataxia Telangiectasia | 1 | 2010 | 13 | 0.080 |
Why?
|
| Genes, Lethal | 1 | 2010 | 57 | 0.080 |
Why?
|
| Homozygote | 1 | 2010 | 122 | 0.080 |
Why?
|
| Models, Genetic | 1 | 2011 | 266 | 0.080 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1994 | 449 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 2010 | 71 | 0.080 |
Why?
|
| Oncogenes | 1 | 2010 | 70 | 0.080 |
Why?
|
| Embryo, Mammalian | 2 | 2007 | 158 | 0.080 |
Why?
|
| Immunoglobulin Class Switching | 1 | 2010 | 82 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2010 | 152 | 0.070 |
Why?
|
| Cell Survival | 1 | 2010 | 587 | 0.070 |
Why?
|
| Up-Regulation | 1 | 2010 | 374 | 0.070 |
Why?
|
| Cell Cycle | 1 | 2010 | 398 | 0.070 |
Why?
|
| Alleles | 2 | 2003 | 453 | 0.070 |
Why?
|
| Sequence Homology, Amino Acid | 4 | 1996 | 364 | 0.070 |
Why?
|
| Immunoglobulin G | 1 | 2010 | 465 | 0.070 |
Why?
|
| Mice, Transgenic | 1 | 2011 | 1290 | 0.070 |
Why?
|
| DNA Damage | 1 | 2010 | 297 | 0.070 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2007 | 46 | 0.070 |
Why?
|
| Genes, p53 | 2 | 2007 | 51 | 0.060 |
Why?
|
| Molecular Sequence Data | 5 | 1996 | 1979 | 0.060 |
Why?
|
| Morphogenesis | 2 | 1997 | 120 | 0.060 |
Why?
|
| Obesity | 1 | 2015 | 1273 | 0.060 |
Why?
|
| Genetic Complementation Test | 2 | 1997 | 67 | 0.060 |
Why?
|
| Base Sequence | 4 | 1996 | 1332 | 0.060 |
Why?
|
| Male | 4 | 2015 | 31039 | 0.060 |
Why?
|
| Genotype | 1 | 2007 | 673 | 0.060 |
Why?
|
| Transforming Growth Factor beta | 2 | 1997 | 181 | 0.060 |
Why?
|
| Proteins | 1 | 2010 | 764 | 0.050 |
Why?
|
| Phosphotransferases | 1 | 2004 | 22 | 0.050 |
Why?
|
| Transcriptional Activation | 2 | 2003 | 197 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2004 | 33 | 0.050 |
Why?
|
| Cyclins | 1 | 2004 | 41 | 0.050 |
Why?
|
| Protein Binding | 3 | 1997 | 1640 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1997 | 663 | 0.050 |
Why?
|
| Acetylation | 1 | 2003 | 121 | 0.050 |
Why?
|
| ras Proteins | 1 | 2003 | 76 | 0.050 |
Why?
|
| Gene Targeting | 1 | 2003 | 77 | 0.050 |
Why?
|
| Sequence Analysis, DNA | 1 | 2004 | 414 | 0.050 |
Why?
|
| Mice, SCID | 1 | 2003 | 518 | 0.040 |
Why?
|
| Transcription Factors | 3 | 2004 | 1556 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2010 | 1222 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 676 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2003 | 268 | 0.040 |
Why?
|
| Activating Transcription Factor 2 | 2 | 1997 | 13 | 0.040 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 2 | 1997 | 45 | 0.040 |
Why?
|
| Sequence Alignment | 3 | 1996 | 300 | 0.040 |
Why?
|
| Cloning, Molecular | 3 | 1996 | 385 | 0.040 |
Why?
|
| Humans | 6 | 2011 | 65111 | 0.040 |
Why?
|
| In Vitro Techniques | 2 | 2003 | 491 | 0.040 |
Why?
|
| Female | 4 | 2011 | 34010 | 0.040 |
Why?
|
| Ectoderm | 1 | 1997 | 12 | 0.030 |
Why?
|
| Epithelial Cells | 2 | 1997 | 413 | 0.030 |
Why?
|
| Genes, Insect | 1 | 1997 | 98 | 0.030 |
Why?
|
| Neoplasms | 1 | 2007 | 1368 | 0.030 |
Why?
|
| Point Mutation | 1 | 1997 | 168 | 0.030 |
Why?
|
| Aging | 1 | 2003 | 771 | 0.030 |
Why?
|
| DNA, Complementary | 1 | 1996 | 165 | 0.030 |
Why?
|
| Time Factors | 1 | 2004 | 3762 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 1996 | 129 | 0.030 |
Why?
|
| Substrate Specificity | 1 | 1996 | 341 | 0.030 |
Why?
|
| CDC2-CDC28 Kinases | 1 | 1995 | 6 | 0.030 |
Why?
|
| G1 Phase | 1 | 1995 | 58 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 260 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 1994 | 391 | 0.030 |
Why?
|
| HeLa Cells | 1 | 1994 | 541 | 0.020 |
Why?
|
| Phenotype | 1 | 1996 | 1233 | 0.020 |
Why?
|
| Protein Biosynthesis | 1 | 1995 | 332 | 0.020 |
Why?
|
| Kinetics | 2 | 2007 | 760 | 0.020 |
Why?
|
| Mammary Glands, Animal | 1 | 2010 | 76 | 0.020 |
Why?
|
| Cell Separation | 1 | 2010 | 147 | 0.020 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2010 | 88 | 0.020 |
Why?
|
| Cytidine Deaminase | 1 | 2010 | 86 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2010 | 576 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 542 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 611 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2010 | 868 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 663 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2007 | 513 | 0.010 |
Why?
|
| Cell Line | 2 | 2003 | 2024 | 0.010 |
Why?
|
| E2F Transcription Factors | 1 | 2004 | 16 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2004 | 58 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 2293 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2003 | 77 | 0.010 |
Why?
|
| Mice, Nude | 1 | 2003 | 286 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2004 | 226 | 0.010 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 1996 | 5 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1996 | 30 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 1996 | 138 | 0.010 |
Why?
|
| Enzyme Repression | 1 | 1995 | 2 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 1995 | 19 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 1995 | 30 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 1995 | 18 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1994 | 193 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 1995 | 52 | 0.010 |
Why?
|
| Conserved Sequence | 1 | 1994 | 173 | 0.010 |
Why?
|
| Tumor Cells, Cultured | 1 | 1994 | 426 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 1996 | 210 | 0.010 |
Why?
|
| Drug Resistance | 1 | 1995 | 154 | 0.010 |
Why?
|
| Down-Regulation | 1 | 1995 | 324 | 0.010 |
Why?
|
| Transfection | 1 | 1994 | 700 | 0.010 |
Why?
|
| Binding Sites | 1 | 1994 | 921 | 0.010 |
Why?
|
| Cytokines | 1 | 1996 | 952 | 0.010 |
Why?
|
| Gene Expression | 1 | 1994 | 852 | 0.010 |
Why?
|
| Models, Molecular | 1 | 1994 | 1162 | 0.010 |
Why?
|
| Lung | 1 | 1995 | 966 | 0.000 |
Why?
|
| Models, Biological | 1 | 1995 | 1192 | 0.000 |
Why?
|
| RNA, Messenger | 1 | 1995 | 1574 | 0.000 |
Why?
|